vimarsana.com
Home
Live Updates
Sequana Medical NV: Sequana Medical announces 2022 Full Year
Sequana Medical NV: Sequana Medical announces 2022 Full Year
Sequana Medical NV: Sequana Medical announces 2022 Full Year Results and 2023 Outlook
PRESS RELEASEREGULATED INFORMATION09 February 2023, 07:00 CEST alfapump® - successful primary endpoint read-out of North American pivotal POSEIDON study / PMA1 filing planned for H2 2023DSR®
Related Keywords
Mexico ,
Machelen ,
Region Flamande ,
Belgium ,
United States ,
Hong Kong ,
China ,
Canada ,
Ukraine ,
America ,
American ,
Cian Crosbie ,
Peter Dhondt ,
Jonathan Edwards ,
Sequana Medicalexpressly ,
Doug Kohrs ,
Nick Bastin ,
Schwierige Zeiten ,
Alexandra Clyde ,
York Heart Association ,
Good Laboratory Practice ,
Strategic Communications ,
Company Notified Body ,
Company Or Sequanamedical ,
Medicaid Services ,
Liver International ,
North American ,
Direct Sodium Removal ,
Euronext Brussels ,
Chief Executive Officer ,
Sequana Medical ,
North America ,
Rosetta Capital ,
Pivotal Cohort ,
Post Marketing Surveillance Registry ,
International Association ,
Seattle Heart Failure ,
Short Term ,
Medical Device Regulation ,
Notified Body ,
Kreos Capital ,
Thousand Euros ,
Loss Per Share ,
Not Meaningful ,
Bootstrap Warrants ,
Kreos Subscription Rights ,
Executive Management ,
Annual Report ,
General Meeting ,
Pre Market Approval ,
Pricewaterhousecoopers Bedrijfsrevisoren ,
Peterd Hondt ,
New York Heart Association ,
Seattle Heart Failure Model ,
Good Laboratory ,
Investigational New ,
Quality Management ,
Sequana ,
Medical ,
Nnounces ,
022 ,
Bull ,
Ear ,
Results ,
023 ,
Outlook ,